Shazib Pervaiz

Pervaiz Shazib

Appointment(s)
  • Professor, Department of Physiology
Academic Qualifications
  • PhD, Southern Methodist University, USA
  • MBBS, King Edward Medical College, Pakistan
  • Fellowship, Cancer Immunology, Harvard Medical School/Massachusetts General Hospital, USA
Research Interest(s)
  • Apoptosis
  • Autophagy
  • ROS Biology
  • Mitochondrial Metabolism
  • Bcl-2 Family
  • p53
  • Rase
  • c-myc
  • PP2A
Recent Publications
  • 1. Pohl SO-G, Agostino M, Dharmarajan A, Pervaiz S. 2018 Jan. Crosstalk between cellular redox state and the anti-apoptotic protein Bcl-2. Antioxid Redox Signal. doi:10.1089/ars.2017.7414.
  • 2. Angelina C, Tan ISY, Choo Z, Lee OZJ, Pervaiz S, Chen ZX. 2017 Dec. KIF1B beta increases ROS to mediate apoptosis and reinforces its protein expression through O-2(-) in a positive feedback mechanism in neuroblastoma. Scientific Reports. 7:16867. doi:10.1038/s41598-017-17192-6.
  • 3. Wong ALA, Hirpara JL, Pervaiz S, Eu J-Q, Sethi G, Goh BC. 2017 Jan. Do STAT3 inhibitors have potential in the future for cancer therapy? Expert Opinion on Investigational Drugs. 26(8):883-887. doi:10.1080/13543784.2017.1351941.
  • 4. Hirpara JL, Loh T, Ng SB, Chng WJ, Pervaiz S. 2016 Dec. Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas. Oncotarget. 7(51):83964-83975. doi:10.18632/oncotarget.13336.
  • 5. Raman D, Foo CHJ, Clement M-V, Pervaiz S. 2016 Aug. Breast Cancer: A Molecular and Redox Snapshot. Antioxidants and Redox Signalling. 25(6):337-370. doi:10.1089/ars.2015.6546.